To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer
(VERU-100 Trial)

Recruiting in Palo Alto (17 mi)

+19 other locations

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1 & 2

Waitlist Available

Sponsor: Veru Inc.

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial is testing VERU-100, a new drug, to see if it can lower and maintain low testosterone levels in men with advanced prostate cancer. By reducing testosterone, the drug aims to control the progression of the cancer.

Eligibility Criteria

Inclusion Criteria

Be over 18 years of age

Have histologically confirmed prostate cancer

Have prostate cancer staged T3-4NxMx or TxN1Mx or TxNxM1 according to the TNM classification or the patient should have rising PSA after failed local therapy and be candidate for androgen deprivation therapy

See 13 more

Exclusion Criteria

History of Torsade de Pointes

Currently taking QT-prolonging drugs

Use of exogenous testosterone within 6 months of Screening Visit

See 14 more